000 05050nam a22004575i 4500
001 978-0-387-30939-2
003 DE-He213
005 20250710083947.0
007 cr nn 008mamaa
008 100301s2006 xxu| s |||| 0|eng d
020 _a9780387309392
_a99780387309392
024 7 _a10.1007/0-387-30939-X
_2doi
082 0 4 _a610.28
_223
100 1 _aDib, Nabil.
_eeditor.
245 1 0 _aStem Cell Therapy and Tissue Engineering for Cardiovascular Repair
_h[recurso electrónico] :
_bFrom Basic Research to Clinical Applications /
_cedited by Nabil Dib, Doris A. Taylor, Edward B. Diethrich.
264 1 _aBoston, MA :
_bSpringer US,
_c2006.
300 _aXIX, 335 p. 91illus., 64 in color. With CD-ROM.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aMyocardial Remodeling -- Ventricular Remodeling In Ischemic Cardiomyopathy -- Myocardial Regeneration -- Myocardial Regeneration: Which Cell and Why -- Cardiac Stem Cells -- Cardiac Stem Cells for Myocardial Regeneration -- Skeletal Myoblast -- A Historic Recapitulation of Myoblast Transplantation -- Myoblast Cell Transplantation: Preclinical Studies -- Skeletal Myoblasts: The European Experience -- Skeletal Myoblasts: The U.S. Experience -- Progenitor Cells -- Progenitor Cells for Cardiac Regeneration -- Bone Marrow -- Bone Marrow-Derived Stem Cell for Myocardial Regeneration: Preclinical Experience -- Bone Marrow Derived Stem Cells for Myocardial Regeneration: Clinical Experience, Surgical Delivery -- Autologous Mononuclear Bone Marrow Cell Transplantion for Myocardial Infarction: The German Experience -- Autologous Mononuclear Bone Marrow Transplantation for Myocardial Infarction: The Spanish Experience -- Mobilizing Bone Marrow Stem Cells for Myocardial Repair After Acute Myocardial Infarction -- Percutaneous Stem Cell Transplantation -- Percutaneous Myoblast Transplantation: Steps In Translational Research -- A Porcine Model of Myocardial Infarction for Evaluation of Cell Transplantation -- Tissue Engineering -- Tissue Engineering for Myocardial Regeneration -- Functional and Electrophysiological Assessment after Cell Tranplantation -- The Role of Pet Scan in Stem Cell Therapy -- The Measurement of Systolic Function in the Mammalian Heart -- Electrophysiological Aspects of Cell Transplantation -- Regulatory Perspective -- Regulatory Considerations in Manufacturing, Product Testing, and Preclinical Development of Cellular Products for Cardiac Repair.
520 _aStem Cell Therapy & Tissue Engineering for Cardiovascular Repair Dib, Taylor, Diethrich Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair serves as an essential reference material covering these emerging technologies in cardiovascular research. Written by prominent world authorities presenting commissioned summaries, Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair discusses the spectrum of stem cell and tissue engineering from basic research to clinical applications, offering a comprehensive, integrated reference.  Key Features: Covers the fields of translational research and clinical applications including, - Pertinent information on cell isolation, expansion, and delivery, both in animals and humans - Overview of embryonic, bone marrow, and myoblast cell culturing and transplantation - Detailed explanations of the FDA regulatory pathways for cell production - Preclinical requirements for investigational new drug applications. - Regulatory requirements that can be applied to a variety of stem cell therapies Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair is essential for all cardiovascular research scientists, clinical researchers, and industry professionals wishing to take advantage of the latest and greatest in the continuously emerging field of stem cell therapy and tissue engineering for cardiovascular repair. the Editors: Nabil Dib, M.D., M.Sc, F.A.C.C, Director of Interventional Cardiology Research, Arizona Heart Institute and Heart Hospital, Phoenix, Arizona Doris Taylor, Ph.D., Bakken Professor, Director, Center for Cardiovascular Repair, University of Minnesota, Minneapolis, Minnesota Edward B. Diethrich, M.D., Medical Director, Arizona Heart Institute and Heart Hospital, Phoenix, Arizona.
650 0 _aENGINEERING.
650 0 _aMEDICINE.
650 0 _aCARDIOLOGY.
650 0 _aBIOMEDICAL ENGINEERING.
650 1 4 _aENGINEERING.
650 2 4 _aBIOMEDICAL ENGINEERING.
650 2 4 _aCARDIOLOGY.
650 2 4 _aBIOMEDICINE GENERAL.
700 1 _aTaylor, Doris A.
_eeditor.
700 1 _aDiethrich, Edward B.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9780387257884
856 4 0 _uhttp://dx.doi.org/10.1007/0-387-30939-X
_zVer el texto completo en las instalaciones del CICY
912 _aZDB-2-ENG
942 _2ddc
_cER
999 _c57093
_d57093